You are using an outdated browser. Please
upgrade your browser to improve your experience.
Release MSS5 Clinical Study App
Release MSS5
by Parallel 6, Inc.
What is it about?
Release MSS5 Clinical Study App. contains content that is new and is tailored for the phase 3 study of Nabiximols Oromucosal Spray entitled:
App Details
Version
1.0.0
Rating
NA
Size
94Mb
Genre
Medical
Last updated
June 3, 2021
Release date
June 3, 2021
More info
App Screenshots
App Store Description
Release MSS5 Clinical Study App. contains content that is new and is tailored for the phase 3 study of Nabiximols Oromucosal Spray entitled:
A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis. The clinical study app. enables study participants to complete daily eDiary entries and view scheduled study appointments during study participation.
GWSP20105 – Study Participant App. The App does not provide medical advice. Please consult with your study doctor with any questions or concerns you may have regarding your individual needs or medical conditions or any related questions about your involvement in the study.
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
